nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromodiphenhydramine—Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.0895	0.112	CrCrCtD
Bromodiphenhydramine—Doxepin—Oxcarbazepine—epilepsy syndrome	0.0877	0.11	CrCrCtD
Bromodiphenhydramine—Chlorcyclizine—Clobazam—epilepsy syndrome	0.0747	0.0934	CrCrCtD
Bromodiphenhydramine—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.0739	0.0924	CrCrCtD
Bromodiphenhydramine—SLC22A6—Acetazolamide—epilepsy syndrome	0.0717	0.572	CbGbCtD
Bromodiphenhydramine—Dimetacrine—Carbamazepine—epilepsy syndrome	0.0696	0.087	CrCrCtD
Bromodiphenhydramine—Imipramine—Carbamazepine—epilepsy syndrome	0.0667	0.0834	CrCrCtD
Bromodiphenhydramine—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.0641	0.0802	CrCrCtD
Bromodiphenhydramine—Imipramine—Oxcarbazepine—epilepsy syndrome	0.0615	0.0769	CrCrCtD
Bromodiphenhydramine—Benzphetamine—Phenytoin—epilepsy syndrome	0.0593	0.0741	CrCrCtD
Bromodiphenhydramine—SLC22A6—Valproic Acid—epilepsy syndrome	0.0536	0.428	CbGbCtD
Bromodiphenhydramine—Diphenhydramine—Phenytoin—epilepsy syndrome	0.0526	0.0658	CrCrCtD
Bromodiphenhydramine—Promazine—Carbamazepine—epilepsy syndrome	0.0522	0.0653	CrCrCtD
Bromodiphenhydramine—Promazine—Oxcarbazepine—epilepsy syndrome	0.0481	0.0601	CrCrCtD
Bromodiphenhydramine—Dimenhydrinate—CHRM2—epilepsy syndrome	0.00038	0.0382	CrCbGaD
Bromodiphenhydramine—Cyclopentolate—CHRM3—epilepsy syndrome	0.000367	0.0368	CrCbGaD
Bromodiphenhydramine—Cyclopentolate—CHRM1—epilepsy syndrome	0.000342	0.0343	CrCbGaD
Bromodiphenhydramine—Imipramine—KCND2—epilepsy syndrome	0.000318	0.0319	CrCbGaD
Bromodiphenhydramine—Amitriptyline—KCND2—epilepsy syndrome	0.000316	0.0317	CrCbGaD
Bromodiphenhydramine—Amitriptyline—KCNQ2—epilepsy syndrome	0.000294	0.0295	CrCbGaD
Bromodiphenhydramine—Amitriptyline—KCNQ3—epilepsy syndrome	0.000294	0.0295	CrCbGaD
Bromodiphenhydramine—Doxylamine—CHRM1—epilepsy syndrome	0.000288	0.0289	CrCbGaD
Bromodiphenhydramine—Amitriptyline—NTRK2—epilepsy syndrome	0.00025	0.0251	CrCbGaD
Bromodiphenhydramine—Orphenadrine—SCN9A—epilepsy syndrome	0.000244	0.0245	CrCbGaD
Bromodiphenhydramine—Tolterodine—CHRM3—epilepsy syndrome	0.000234	0.0235	CrCbGaD
Bromodiphenhydramine—Cyclopentolate—BCHE—epilepsy syndrome	0.000233	0.0234	CrCbGaD
Bromodiphenhydramine—Orphenadrine—SCN4A—epilepsy syndrome	0.000224	0.0225	CrCbGaD
Bromodiphenhydramine—Tolterodine—CHRM1—epilepsy syndrome	0.000218	0.0219	CrCbGaD
Bromodiphenhydramine—Dimetindene—CHRM2—epilepsy syndrome	0.000205	0.0206	CrCbGaD
Bromodiphenhydramine—Tolterodine—CHRM2—epilepsy syndrome	0.000178	0.0179	CrCbGaD
Bromodiphenhydramine—Brompheniramine—CHRM3—epilepsy syndrome	0.000174	0.0175	CrCbGaD
Bromodiphenhydramine—Orphenadrine—SCN1A—epilepsy syndrome	0.000164	0.0165	CrCbGaD
Bromodiphenhydramine—Brompheniramine—CHRM1—epilepsy syndrome	0.000162	0.0163	CrCbGaD
Bromodiphenhydramine—Brompheniramine—CHRM2—epilepsy syndrome	0.000132	0.0133	CrCbGaD
Bromodiphenhydramine—Hydroxyzine—CYP2D6—epilepsy syndrome	0.000122	0.0122	CrCbGaD
Bromodiphenhydramine—Doxepin—CHRM3—epilepsy syndrome	0.000112	0.0113	CrCbGaD
Bromodiphenhydramine—Fluoxetine—SLC6A4—epilepsy syndrome	0.000111	0.0111	CrCbGaD
Bromodiphenhydramine—Mepyramine—CYP2D6—epilepsy syndrome	0.000111	0.0111	CrCbGaD
Bromodiphenhydramine—Tolterodine—CYP2C19—epilepsy syndrome	0.00011	0.011	CrCbGaD
Bromodiphenhydramine—Fluoxetine—CYP2C19—epilepsy syndrome	0.000105	0.0105	CrCbGaD
Bromodiphenhydramine—Doxepin—CHRM1—epilepsy syndrome	0.000105	0.0105	CrCbGaD
Bromodiphenhydramine—Tripelennamine—CYP2D6—epilepsy syndrome	0.000102	0.0103	CrCbGaD
Bromodiphenhydramine—Amitriptyline—OPRD1—epilepsy syndrome	0.000102	0.0103	CrCbGaD
Bromodiphenhydramine—Promazine—CHRM3—epilepsy syndrome	9.98e-05	0.01	CrCbGaD
Bromodiphenhydramine—Carbinoxamine—CYP2C19—epilepsy syndrome	9.43e-05	0.00947	CrCbGaD
Bromodiphenhydramine—Benzphetamine—ADRA2A—epilepsy syndrome	9.39e-05	0.00943	CrCbGaD
Bromodiphenhydramine—Promazine—CHRM1—epilepsy syndrome	9.31e-05	0.00935	CrCbGaD
Bromodiphenhydramine—Cyclobenzaprine—HTR2A—epilepsy syndrome	9.29e-05	0.00933	CrCbGaD
Bromodiphenhydramine—Diphenhydramine—CHRM2—epilepsy syndrome	8.81e-05	0.00885	CrCbGaD
Bromodiphenhydramine—Imipramine—CHRM3—epilepsy syndrome	8.74e-05	0.00878	CrCbGaD
Bromodiphenhydramine—Amitriptyline—CHRM3—epilepsy syndrome	8.69e-05	0.00872	CrCbGaD
Bromodiphenhydramine—Doxepin—CHRM2—epilepsy syndrome	8.55e-05	0.00859	CrCbGaD
Bromodiphenhydramine—Fluoxetine—HTR2A—epilepsy syndrome	8.5e-05	0.00853	CrCbGaD
Bromodiphenhydramine—Cyclobenzaprine—CYP2D6—epilepsy syndrome	8.5e-05	0.00853	CrCbGaD
Bromodiphenhydramine—Chlorphenamine—SLC6A4—epilepsy syndrome	8.46e-05	0.00849	CrCbGaD
Bromodiphenhydramine—Orphenadrine—CHRM2—epilepsy syndrome	8.34e-05	0.00837	CrCbGaD
Bromodiphenhydramine—Brompheniramine—CYP2C19—epilepsy syndrome	8.17e-05	0.0082	CrCbGaD
Bromodiphenhydramine—Imipramine—CHRM1—epilepsy syndrome	8.15e-05	0.00819	CrCbGaD
Bromodiphenhydramine—Tolterodine—CYP2D6—epilepsy syndrome	8.15e-05	0.00818	CrCbGaD
Bromodiphenhydramine—Amitriptyline—CHRM1—epilepsy syndrome	8.1e-05	0.00814	CrCbGaD
Bromodiphenhydramine—Amitriptyline—OPRM1—epilepsy syndrome	7.82e-05	0.00785	CrCbGaD
Bromodiphenhydramine—Fenoprofen—PTGS2—epilepsy syndrome	7.78e-05	0.00781	CrCbGaD
Bromodiphenhydramine—Fluoxetine—CYP2D6—epilepsy syndrome	7.77e-05	0.00781	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CX3CL1—epilepsy syndrome	7.77e-05	0.00119	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—BDKRB1—epilepsy syndrome	7.77e-05	0.00119	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	7.7e-05	0.00118	CbGpPWpGaD
Bromodiphenhydramine—Tamoxifen—ABCC2—epilepsy syndrome	7.62e-05	0.00765	CrCbGaD
Bromodiphenhydramine—Promazine—CHRM2—epilepsy syndrome	7.6e-05	0.00764	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—GABBR1—epilepsy syndrome	7.56e-05	0.00116	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	7.52e-05	0.00116	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	7.52e-05	0.00116	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—SSTR5—epilepsy syndrome	7.39e-05	0.00113	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—SSTR4—epilepsy syndrome	7.39e-05	0.00113	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	7.36e-05	0.00113	CbGpPWpGaD
Bromodiphenhydramine—Doxepin—ADRA2A—epilepsy syndrome	7.3e-05	0.00733	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HRH3—epilepsy syndrome	7.25e-05	0.00111	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	7.22e-05	0.00111	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.17e-05	0.0011	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—HTR2A—epilepsy syndrome	7.16e-05	0.0011	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—OPRM1—epilepsy syndrome	7.13e-05	0.0011	CbGpPWpGaD
Bromodiphenhydramine—Atomoxetine—SLC6A4—epilepsy syndrome	7.1e-05	0.00714	CrCbGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCR10—epilepsy syndrome	7.08e-05	0.00109	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	7.07e-05	0.00109	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	7.07e-05	0.00109	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	7.04e-05	0.00108	CbGpPWpGaD
Bromodiphenhydramine—Toremifene—ABCB1—epilepsy syndrome	7.02e-05	0.00705	CrCbGaD
Bromodiphenhydramine—Carbinoxamine—CYP2D6—epilepsy syndrome	6.99e-05	0.00702	CrCbGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	6.94e-05	0.00107	CbGpPWpGaD
Bromodiphenhydramine—Fenoprofen—ALB—epilepsy syndrome	6.93e-05	0.00696	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GRM2—epilepsy syndrome	6.82e-05	0.00105	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—AGT—epilepsy syndrome	6.8e-05	0.00104	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	6.77e-05	0.00104	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CCR3—epilepsy syndrome	6.74e-05	0.00103	CbGpPWpGaD
Bromodiphenhydramine—Tamoxifen—ABCG2—epilepsy syndrome	6.74e-05	0.00677	CrCbGaD
Bromodiphenhydramine—Atomoxetine—CYP2C19—epilepsy syndrome	6.73e-05	0.00676	CrCbGaD
Bromodiphenhydramine—Imipramine—CHRM2—epilepsy syndrome	6.66e-05	0.00668	CrCbGaD
Bromodiphenhydramine—Imipramine—HTR7—epilepsy syndrome	6.62e-05	0.00665	CrCbGaD
Bromodiphenhydramine—Amitriptyline—CHRM2—epilepsy syndrome	6.61e-05	0.00664	CrCbGaD
Bromodiphenhydramine—Amitriptyline—HTR7—epilepsy syndrome	6.58e-05	0.00661	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—NPY—epilepsy syndrome	6.57e-05	0.00101	CbGpPWpGaD
Bromodiphenhydramine—Promazine—ADRA2A—epilepsy syndrome	6.49e-05	0.00652	CrCbGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	6.41e-05	0.000984	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CXCL2—epilepsy syndrome	6.34e-05	0.000973	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CRH—epilepsy syndrome	6.34e-05	0.000973	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—OXT—epilepsy syndrome	6.34e-05	0.000973	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CCL3—epilepsy syndrome	6.34e-05	0.000973	CbGpPWpGaD
Bromodiphenhydramine—HRH1—IL-4 Signaling Pathway—AKT1—epilepsy syndrome	6.2e-05	0.000952	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GRM2—epilepsy syndrome	6.19e-05	0.000951	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—SSTR3—epilepsy syndrome	6.16e-05	0.000947	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	6.08e-05	0.000934	CbGpPWpGaD
Bromodiphenhydramine—Brompheniramine—CYP2D6—epilepsy syndrome	6.05e-05	0.00608	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	5.98e-05	0.000919	CbGpPWpGaD
Bromodiphenhydramine—Chlorphenamine—CYP2D6—epilepsy syndrome	5.94e-05	0.00597	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	5.91e-05	0.000908	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—NPY2R—epilepsy syndrome	5.91e-05	0.000908	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—SSTR1—epilepsy syndrome	5.91e-05	0.000908	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCR9—epilepsy syndrome	5.91e-05	0.000908	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCR8—epilepsy syndrome	5.91e-05	0.000908	CbGpPWpGaD
Bromodiphenhydramine—Fluoxetine—ALB—epilepsy syndrome	5.82e-05	0.00584	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GRM3—epilepsy syndrome	5.79e-05	0.00089	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GRM4—epilepsy syndrome	5.79e-05	0.00089	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—SST—epilepsy syndrome	5.73e-05	0.00088	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CCR2—epilepsy syndrome	5.73e-05	0.00088	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	5.71e-05	0.000877	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	5.7e-05	0.000876	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—SSTR2—epilepsy syndrome	5.69e-05	0.000874	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	5.66e-05	0.000869	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—ADRA2A—epilepsy syndrome	5.65e-05	0.00567	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—ADRA2A—epilepsy syndrome	5.61e-05	0.000861	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—SSTR3—epilepsy syndrome	5.6e-05	0.00086	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	5.59e-05	0.000859	CbGpPWpGaD
Bromodiphenhydramine—Doxepin—SLC6A4—epilepsy syndrome	5.57e-05	0.00559	CrCbGaD
Bromodiphenhydramine—Fluoxetine—ABCB1—epilepsy syndrome	5.55e-05	0.00557	CrCbGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	5.55e-05	0.000852	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	5.54e-05	0.000851	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PRICKLE1—epilepsy syndrome	5.52e-05	0.000848	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PRDM4—epilepsy syndrome	5.52e-05	0.000848	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GRM8—epilepsy syndrome	5.49e-05	0.000844	CbGpPWpGaD
Bromodiphenhydramine—Atomoxetine—HTR2A—epilepsy syndrome	5.46e-05	0.00548	CrCbGaD
Bromodiphenhydramine—Diphenhydramine—CYP2C19—epilepsy syndrome	5.44e-05	0.00546	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—BDKRB2—epilepsy syndrome	5.39e-05	0.000827	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CXCL12—epilepsy syndrome	5.39e-05	0.000827	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ARHGEF9—epilepsy syndrome	5.37e-05	0.000824	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—SSTR1—epilepsy syndrome	5.37e-05	0.000824	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCR9—epilepsy syndrome	5.37e-05	0.000824	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—NPY2R—epilepsy syndrome	5.37e-05	0.000824	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCR8—epilepsy syndrome	5.37e-05	0.000824	CbGpPWpGaD
Bromodiphenhydramine—Tamoxifen—CYP2C19—epilepsy syndrome	5.3e-05	0.00532	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CNR1—epilepsy syndrome	5.29e-05	0.000812	CbGpPWpGaD
Bromodiphenhydramine—Doxepin—CYP2C19—epilepsy syndrome	5.28e-05	0.0053	CrCbGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GRM4—epilepsy syndrome	5.26e-05	0.000808	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GRM3—epilepsy syndrome	5.26e-05	0.000808	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—OPRD1—epilepsy syndrome	5.24e-05	0.000805	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—SSTR2—epilepsy syndrome	5.17e-05	0.000793	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HTR7—epilepsy syndrome	5.16e-05	0.000792	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CHRM1—epilepsy syndrome	5.02e-05	0.000772	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PDYN—epilepsy syndrome	5.02e-05	0.000772	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GRM1—epilepsy syndrome	5.02e-05	0.000772	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCR7—epilepsy syndrome	5.02e-05	0.000772	CbGpPWpGaD
Bromodiphenhydramine—Atomoxetine—CYP2D6—epilepsy syndrome	4.99e-05	0.00501	CrCbGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GRM8—epilepsy syndrome	4.99e-05	0.000766	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	4.85e-05	0.000745	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ACKR4—epilepsy syndrome	4.82e-05	0.000741	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—OPRD1—epilepsy syndrome	4.76e-05	0.000731	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GNAO1—epilepsy syndrome	4.76e-05	0.000731	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	4.74e-05	0.000729	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GAL—epilepsy syndrome	4.72e-05	0.000726	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.69e-05	0.000721	CbGpPWpGaD
Bromodiphenhydramine—Promazine—CYP2C19—epilepsy syndrome	4.69e-05	0.00471	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GRM5—epilepsy syndrome	4.67e-05	0.000717	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CHRM3—epilepsy syndrome	4.67e-05	0.000717	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.65e-05	0.000715	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PDYN—epilepsy syndrome	4.56e-05	0.000701	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CHRM1—epilepsy syndrome	4.56e-05	0.000701	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCR7—epilepsy syndrome	4.56e-05	0.000701	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GRM1—epilepsy syndrome	4.56e-05	0.000701	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.51e-05	0.000692	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	4.5e-05	0.000691	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CHRM2—epilepsy syndrome	4.39e-05	0.000675	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	4.39e-05	0.000675	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SSTR5—epilepsy syndrome	4.36e-05	0.00067	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SSTR4—epilepsy syndrome	4.36e-05	0.00067	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—AVP—epilepsy syndrome	4.34e-05	0.000667	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—SLC6A4—epilepsy syndrome	4.33e-05	0.00435	CrCbGaD
Bromodiphenhydramine—Amitriptyline—SLC6A4—epilepsy syndrome	4.31e-05	0.00433	CrCbGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GAL—epilepsy syndrome	4.29e-05	0.000659	CbGpPWpGaD
Bromodiphenhydramine—Doxepin—HTR2A—epilepsy syndrome	4.28e-05	0.0043	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GABBR1—epilepsy syndrome	4.27e-05	0.000656	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CHRM3—epilepsy syndrome	4.24e-05	0.000652	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GRM5—epilepsy syndrome	4.24e-05	0.000652	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCR10—epilepsy syndrome	4.18e-05	0.000642	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—CYP2C19—epilepsy syndrome	4.11e-05	0.00413	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HRH3—epilepsy syndrome	4.1e-05	0.000629	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—CYP2C19—epilepsy syndrome	4.08e-05	0.0041	CrCbGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CX3CR1—epilepsy syndrome	4.07e-05	0.000625	CbGpPWpGaD
Bromodiphenhydramine—Diphenhydramine—CYP2D6—epilepsy syndrome	4.03e-05	0.00405	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—OPRM1—epilepsy syndrome	4.03e-05	0.000619	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—BDKRB1—epilepsy syndrome	3.99e-05	0.000613	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CHRM2—epilepsy syndrome	3.99e-05	0.000613	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CX3CL1—epilepsy syndrome	3.99e-05	0.000613	CbGpPWpGaD
Bromodiphenhydramine—Tamoxifen—CYP2D6—epilepsy syndrome	3.93e-05	0.00394	CrCbGaD
Bromodiphenhydramine—Doxepin—CYP2D6—epilepsy syndrome	3.91e-05	0.00393	CrCbGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GABBR1—epilepsy syndrome	3.88e-05	0.000596	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCR3—epilepsy syndrome	3.81e-05	0.000585	CbGpPWpGaD
Bromodiphenhydramine—Promazine—HTR2A—epilepsy syndrome	3.8e-05	0.00382	CrCbGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	3.79e-05	0.000582	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HRH3—epilepsy syndrome	3.72e-05	0.000571	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—NPY—epilepsy syndrome	3.71e-05	0.00057	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	3.71e-05	0.000569	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CCR5—epilepsy syndrome	3.69e-05	0.000567	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—OPRM1—epilepsy syndrome	3.66e-05	0.000562	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GRM2—epilepsy syndrome	3.66e-05	0.000562	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HTR2A—epilepsy syndrome	3.61e-05	0.000555	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CRH—epilepsy syndrome	3.58e-05	0.00055	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—OXT—epilepsy syndrome	3.58e-05	0.00055	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CXCL2—epilepsy syndrome	3.58e-05	0.00055	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCR3—epilepsy syndrome	3.46e-05	0.000531	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—AGT—epilepsy syndrome	3.43e-05	0.000527	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—NPY—epilepsy syndrome	3.37e-05	0.000518	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—HTR2A—epilepsy syndrome	3.33e-05	0.00334	CrCbGaD
Bromodiphenhydramine—Amitriptyline—HTR2A—epilepsy syndrome	3.31e-05	0.00332	CrCbGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SSTR3—epilepsy syndrome	3.31e-05	0.000508	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CXCL2—epilepsy syndrome	3.25e-05	0.000499	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CRH—epilepsy syndrome	3.25e-05	0.000499	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCL3—epilepsy syndrome	3.25e-05	0.000499	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—OXT—epilepsy syndrome	3.25e-05	0.000499	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—SST—epilepsy syndrome	3.24e-05	0.000497	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCR2—epilepsy syndrome	3.24e-05	0.000497	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ST3GAL3—epilepsy syndrome	3.24e-05	0.000497	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ARHGEF9—epilepsy syndrome	3.17e-05	0.000487	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SSTR1—epilepsy syndrome	3.17e-05	0.000487	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCR9—epilepsy syndrome	3.17e-05	0.000487	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCR8—epilepsy syndrome	3.17e-05	0.000487	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NPY2R—epilepsy syndrome	3.17e-05	0.000487	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	3.17e-05	0.000487	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GRM3—epilepsy syndrome	3.11e-05	0.000477	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GRM4—epilepsy syndrome	3.11e-05	0.000477	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DUSP4—epilepsy syndrome	3.05e-05	0.000469	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SSTR2—epilepsy syndrome	3.05e-05	0.000469	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—CYP2D6—epilepsy syndrome	3.05e-05	0.00306	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CXCL12—epilepsy syndrome	3.04e-05	0.000468	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	3.04e-05	0.000468	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—CYP2D6—epilepsy syndrome	3.03e-05	0.00304	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CNR1—epilepsy syndrome	2.99e-05	0.000459	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PLCB1—epilepsy syndrome	2.98e-05	0.000457	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GRM8—epilepsy syndrome	2.95e-05	0.000453	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PGF—epilepsy syndrome	2.95e-05	0.000453	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCR2—epilepsy syndrome	2.94e-05	0.000452	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—SST—epilepsy syndrome	2.94e-05	0.000452	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR7—epilepsy syndrome	2.92e-05	0.000448	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—POMC—epilepsy syndrome	2.89e-05	0.000443	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ADRA2A—epilepsy syndrome	2.88e-05	0.000442	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CCL2—epilepsy syndrome	2.82e-05	0.000434	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.82e-05	0.000433	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GNAO1—epilepsy syndrome	2.81e-05	0.000432	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—OPRD1—epilepsy syndrome	2.81e-05	0.000432	CbGpPWpGaD
Bromodiphenhydramine—Tamoxifen—ABCB1—epilepsy syndrome	2.8e-05	0.00282	CrCbGaD
Bromodiphenhydramine—Doxepin—ABCB1—epilepsy syndrome	2.79e-05	0.00281	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AKT3—epilepsy syndrome	2.78e-05	0.000427	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CXCL12—epilepsy syndrome	2.76e-05	0.000425	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—BDKRB2—epilepsy syndrome	2.76e-05	0.000425	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CNR1—epilepsy syndrome	2.71e-05	0.000417	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PLCB1—epilepsy syndrome	2.7e-05	0.000415	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PDYN—epilepsy syndrome	2.7e-05	0.000414	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CHRM1—epilepsy syndrome	2.7e-05	0.000414	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCR7—epilepsy syndrome	2.7e-05	0.000414	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GRM1—epilepsy syndrome	2.7e-05	0.000414	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR7—epilepsy syndrome	2.65e-05	0.000407	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HBEGF—epilepsy syndrome	2.57e-05	0.000395	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CDC42—epilepsy syndrome	2.53e-05	0.000389	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GFAP—epilepsy syndrome	2.53e-05	0.000389	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GAL—epilepsy syndrome	2.53e-05	0.000389	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AKT3—epilepsy syndrome	2.52e-05	0.000387	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CASP2—epilepsy syndrome	2.51e-05	0.000385	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CHRM3—epilepsy syndrome	2.51e-05	0.000385	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GRM5—epilepsy syndrome	2.51e-05	0.000385	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AVP—epilepsy syndrome	2.45e-05	0.000377	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.4e-05	0.000369	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CHRM2—epilepsy syndrome	2.36e-05	0.000362	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.36e-05	0.000362	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.36e-05	0.000362	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CDC42—epilepsy syndrome	2.3e-05	0.000354	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GABBR1—epilepsy syndrome	2.29e-05	0.000352	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—ALB—epilepsy syndrome	2.26e-05	0.00227	CrCbGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AVP—epilepsy syndrome	2.23e-05	0.000342	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HRH3—epilepsy syndrome	2.2e-05	0.000337	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—ABCB1—epilepsy syndrome	2.17e-05	0.00218	CrCbGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—OPRM1—epilepsy syndrome	2.16e-05	0.000332	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—ABCB1—epilepsy syndrome	2.16e-05	0.00217	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.09e-05	0.00032	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	2.04e-05	0.000314	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.04e-05	0.000314	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.99e-05	0.000306	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NPY—epilepsy syndrome	1.99e-05	0.000306	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	1.94e-05	0.000298	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	1.92e-05	0.000295	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	1.92e-05	0.000295	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CRH—epilepsy syndrome	1.92e-05	0.000295	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—OXT—epilepsy syndrome	1.92e-05	0.000295	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	1.92e-05	0.000295	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	1.89e-05	0.000291	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.85e-05	0.000285	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.79e-05	0.000275	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	1.79e-05	0.000274	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	1.79e-05	0.000274	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	1.76e-05	0.00027	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SST—epilepsy syndrome	1.74e-05	0.000267	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	1.74e-05	0.000267	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	1.74e-05	0.000267	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	1.72e-05	0.000264	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.7e-05	0.000261	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	1.69e-05	0.00026	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	1.63e-05	0.000251	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.63e-05	0.000251	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	1.63e-05	0.00025	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.63e-05	0.00025	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.62e-05	0.000249	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	1.6e-05	0.000246	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	1.6e-05	0.000246	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	1.6e-05	0.000245	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	1.56e-05	0.00024	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	1.52e-05	0.000233	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	1.49e-05	0.000229	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	1.48e-05	0.000227	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	1.46e-05	0.000224	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	1.45e-05	0.000223	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—S100B—epilepsy syndrome	1.38e-05	0.000211	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	1.36e-05	0.000209	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	1.36e-05	0.000209	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	1.32e-05	0.000202	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	1.24e-05	0.000191	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	1.21e-05	0.000186	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	1.21e-05	0.000185	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	1.2e-05	0.000185	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.16e-05	0.000179	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	1.15e-05	0.000177	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	1.12e-05	0.000172	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	1.1e-05	0.000168	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	1.04e-05	0.00016	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	1.04e-05	0.00016	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	1.02e-05	0.000156	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	9.98e-06	0.000153	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	9.6e-06	0.000147	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	9.56e-06	0.000147	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	8.75e-06	0.000134	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	8.56e-06	0.000131	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	7.73e-06	0.000119	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	7.18e-06	0.00011	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	7.04e-06	0.000108	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.54e-06	0.0001	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	6.48e-06	9.95e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	6.29e-06	9.66e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	6.12e-06	9.4e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	5.94e-06	9.12e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	5.64e-06	8.67e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	5.5e-06	8.44e-05	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	3.51e-06	5.39e-05	CbGpPWpGaD
